Riskpilot← Back to searchSign inGet full accessAPPSENS AS
ASActiveOrg 918707719Senterveien 30, 4790 LillesandManufacture of pharmaceutical preparations · NACE 2120Est. 20178 employees
Revenue 2024
NOK 7M
+37% vs 2023
EBITDA margin
-50.0%
+39% vs 2023
Equity ratio
75.3%
Financial strength
Net profit 2024
NOK -8,6M
+33% vs 2023
| Revenue | NOK 7M | +37% |
| EBITDA | NOK -3,5M | +39% |
| Net profit | NOK -8,6M | +33% |
| Total assets | NOK 23,6M | +20% |
| Equity | NOK 17,8M | +25% |
| Employees | 8 | — |
Legal name
APPSENS AS
Org number
918707719
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
17. mars 2017
Share capital
NOK 127 952
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder sammen
Company purpose
Utvikling og investeringer i produkter og tjenester.
Address
Senterveien 30, 4790 Lillesand
Phone
+4797342574
Email
post@appsens.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 400 | 1 543 | 2 242 | 149 | 2 078 | 3 177 | 5 107 | 6 975 |
| Staff expenses | −0 | −597 | −2 424 | −14 | −3 181 | −3 166 | −3 571 | −3 975 |
| EBITDA | 1 | −967 | −8 756 | −528 | −7 303 | −5 095 | −5 747 | −3 485 |
| Depreciation & amort. | −0 | −0 | −31 | −211 | −1 187 | −2 196 | −7 002 | −5 357 |
| EBIT | 1 | −967 | −8 787 | −739 | −8 491 | −7 291 | −12 749 | −8 842 |
| Net financials | 0 | −199 | −188 | 20 | 30 | −104 | −152 | 211 |
| Profit before tax | 1 | −1 166 | −8 975 | −720 | −8 461 | −7 396 | −12 902 | −8 632 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −1 166 | −8 975 | −720 | −8 461 | −7 396 | −12 902 | −8 632 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 585 | 4 297 | 3 119 | 34 541 | 26 880 | 19 578 | 19 692 | 23 650 |
| Equity | 525 | 3 610 | 2 210 | 31 230 | 22 769 | 15 374 | 14 272 | 17 816 |
| Long-term debt | 0 | 0 | 0 | 2 500 | 2 500 | 2 177 | 3 552 | 3 091 |
| Short-term debt | 60 | 687 | 910 | 811 | 1 611 | 2 027 | 1 868 | 2 743 |
| Total debt | 60 | 687 | 910 | 3 311 | 4 111 | 4 204 | 5 420 | 5 834 |
EBITDA margin
-50.0%
This company
15.8%
Market median
-416% vs market
20172024
Equity ratio
75.3%
This company
38.2%
Market median
+97% vs market
20172024
Return on equity
-48.4%
This company
18.4%
Market median
-363% vs market
20172024
Net profit margin
-123.7%
This company
8.1%
Market median
-1627% vs market
20172024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20172024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-03-03 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TY Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bjørn Breien As | Company | 18.7% | 18.7% | 2022 |
Fensli Consulting As | Company | 18.6% | 18.6% | 2022 |
Corsult As | Company | 9.4% | 9.4% | 2022 |
Verd Investering As | Company | 8.3% | 8.3% | 2022 |
| Individual | 7.0% | 7.0% | 2022 | |
Bogaard Consulting As | Company | 7.0% | 7.0% | 2022 |
Lucellum As | Company | 5.4% | 5.4% | 2022 |
Gremsdalen Invest As | Company | 4.8% | 4.8% | 2022 |
Uthalden As | Company | 4.1% | 4.1% | 2022 |
Erbe Invest As | Company | 4.1% | 4.1% | 2022 |
| Individual | 1.6% | 1.6% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fensli Consulting As
APPSENS AS Board members of APPSENS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tord Ytterdahl | Chief Executive Officer | 0 companies |
| Harald Moræus-Hanssen | Board of Directors | 0 companies |
| Morten Andresen | Chairman | 0 companies |
| Åge Nærdal | Board of Directors | 0 companies |
| Andreas Karlsen Eskeland | Board of Directors | 0 companies |
| Anita Tunold | Board of Directors | 0 companies |
| Bjørn Breien | Board of Directors | 0 companies |
| Thomas Ramdahl | Chairman | 0 companies |
| Lars Peder Fosse Fensli | Chairman | 0 companies |
| Axel Kogstad Bendvold | Board of Directors | 0 companies |